Amexdrug Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXRX research report →
Companywww.amexdrug.com
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products.
- CEO
- Jack Amin
- IPO
- 2001
- Employees
- 9
- HQ
- Commerce, CA, US
Price Chart
Valuation
- Market Cap
- $33.88K
- P/E
- 0.66
- P/S
- 0.01
- P/B
- 0.02
- EV/EBITDA
- 2.73
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 45.96%
- Op Margin
- 4.94%
- Net Margin
- 1.73%
- ROE
- 2.84%
- ROIC
- 6.51%
Growth & Income
- Revenue
- $2.90M · -14.61%
- Net Income
- $40.27K · 252.18%
- EPS
- $0.00 · 100.00%
- Op Income
- $136.79K
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.52
- Avg Volume
- 70
Get TickerSpark's AI analysis on AXRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AXRX Coverage
We haven't published any research on AXRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AXRX Report →